Associated Papers
Identification of a De novo pathogenic missense variant (c.559G>A) in CASZ1 associated with dilated cardiomyopathy.
Liu RL et al.
Qjm : Monthly Journal of the Association of Physicians, 2024
Role of the CASZ1 transcription factor in tissue development and disease.
Liu T et al.
European Journal of Medical Research, 2023
Identification of a Novel de Novo Variant in the CASZ1 Causing a Rare Type of Dilated Cardiomyopathy.
Orlova A et al.
International Journal of Molecular Sciences, 2022
A novel de novo CASZ1 heterozygous frameshift variant causes dilated cardiomyopathy and left ventricular noncompaction cardiomyopathy.
Guo J et al.
Molecular Genetics & Genomic Medicine, 2019
CASZ1 loss-of-function mutation contributes to familial dilated cardiomyopathy.
Qiu XB et al.
Clinical Chemistry and Laboratory Medicine, 2017
Select a paper to view details